What You Should Know:
- Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
- The innovative approach could revolutionize the way researchers select patients and ultimately lead to faster development of new treatments.
Unlocking the Power of Genetics for Clinical Trials
Genomics plc brings its expertise in PRS technology to the table.
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Deciphex & Novartis Partner on AI-Powered Pathology for Drug Discovery
What You Should Know:
- Deciphex, a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis, a prominent multinational pharmaceutical corporation.
- The strategic partnership focuses on developing innovative artificial intelligence (AI) solutions aimed at revolutionizing preclinical pathology assessments within the drug discovery and development process.
Optimizing Preclinical Pathology with AI
The collaboration
Read More
COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials
What You Should Know:
- COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
- The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate clinical trials specifically focused on multiple myeloma, a cancer affecting white blood cells. The findings from this partnership have the potential to significantly impact future clinical trial designs for multiple myeloma.
Unlocking
Read More
Isospec Analytics Secures $1.9M to Transform Molecular Identification
What You Should Know:
- When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger.
- Isospec Analytics
Read More
JAPAC Drug Development: Navigating Safety & Regulatory Requirements
The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. This growth benefits contract research organizations, pharma organizations and patients alike, but several factors must be considered for drug development safety and regulatory operations in JAPAC
Read More
Nucleai, GoPath Diagnostics Partner to Power AI-Powered Digital Pathology
What You Should Know:
- Nucleai, a leader in spatial biology and AI, and GoPath Diagnostics, a leading provider of digital pathology and molecular diagnostics, announced a strategic collaboration today.
- The partnership aims to revolutionize clinical trials, diagnostics, and research in oncology and immunology by combining their strengths in AI and real-world data.
Unlocking the Power of Spatial AI Biomarkers
Nucleai specializes in "spatial AI biomarkers." This
Read More
Synchron Launches Patient Registry for Stentrode Brain-Computer Interface
What You Should Know:
- Synchron, a company pioneering brain-computer interface (BCI) technology unveils a community registry that aims to bring together patients with motor impairments, their caregivers, and medical professionals to explore the potential of BCI in restoring lost functionality.
- By uniting patients, caregivers, and medical professionals, this initiative has the potential to revolutionize the way we treat motor impairments and empower individuals to regain control of
Read More
Hartwig Medical, Ultima Genomics Partner to Transform Precision Oncology with Affordable Genetic Testing
What You Should Know:
- Hartwig Medical Foundation, a provider in using comprehensive genetic profiling to improve cancer treatment, and Ultima Genomics, a developer of groundbreaking next-generation sequencing (NGS) technology, announce a groundbreaking collaboration.
- The strategic partnership aims to make whole genome sequencing, the most detailed form of genetic analysis, a more accessible and affordable tool in the fight against cancer.
The Challenge: High Costs Limit
Read More
Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.Culmination Bio and BillionToOne are working together to leverage their respective strengths in order to facilitate the development and validation of robust and impactful oncology
Read More
Manifold Secures $15M to Revolutionize Clinical Research with AI
What You Should Know:
- Manifold, an AI-powered clinical research platform raises $15M in a Series A funding round led by TQ Ventures with participation from Calibrate Ventures, SK Ventures, and existing investors TTCER Partners and Dr. Sachin H. Jain.
- By accelerating research progress, Manifold paves the way for faster development of life-saving treatments and improved patient outcomes.
AI-Powered Clinical Research Platform
Manifold tackles a critical challenge in medical
Read More
